Navigation Links
Poniard Pharmaceuticals Announces Upcoming Conference Participation
Date:8/27/2008

SOUTH SAN FRANCISCO, Calif., Aug. 27 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today announced that Jerry McMahon, Ph.D., chairman and CEO, will participate in three upcoming conferences in September during which he will provide a corporate overview, including a discussion of the clinical development program for picoplatin, the Company's lead product candidate.

-- The Thomas Weisel Partners Healthcare Conference on Wednesday, September 3, at 4:25 p.m. Eastern Time at the Four Seasons Hotel in Boston

-- BioCentury's NewsMakers in the Biotech Industry Conference on Thursday, September 4, at 2:30 p.m. Eastern Time at the Millennium Broadway Hotel in New York

-- The 3rd Annual Citi Biotech Day on Monday, September 8, at 2:35 p.m. Eastern Time at the Citi Center in New York

Live audio webcasts of Poniard's presentations at the Thomas Weisel Partners Healthcare Conference and Citi Biotech Day will be available for 10 business days following each conference. Each webcast can be accessed on the "Events" page of the "News & Events" section of the Company's website at http://www.poniard.com.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. Picoplatin, the Company's lead platform product candidate, is a new generation platinum therapy with an improved safety profile relative to existing platinum-based cancer therapies. Picoplatin is designed to overcome platinum resistance associated with chemotherapy in solid tumors,
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
2. Poniard Pharmaceuticals Announces Upgrade of Stock Listing to NASDAQ Global Market
3. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
5. Poniard Pharmaceuticals Announces Upcoming Conference Participation
6. Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results and Corporate Update
7. Poniard Pharmaceuticals Appoints Four New Members to Clinical Advisory Board
8. Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31
9. Poniard Pharmaceuticals Announces Upcoming Conference Participation
10. Poniard Pharmaceuticals to Present at the 4th Annual Moores UCSD Cancer Center Translational Oncology Symposium
11. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013   Flexion Therapeutics , Inc. today ... to its management team as chief financial ... financial management experience with biotechnology and medical device companies. ... chief financial officer for Novavax (NASDAQ: NVAX ... than $250 million through a combination of investment funding ...
(Date:5/20/2013)... Interventional cardiologist Tony Farah, MD, and ... Cardiovascular Institute have helped pioneer many breakthroughs ... over the past three decades, from new disease-fighting ... coronary artery stent implantation. , Today, AGH officials announced ... role in the study of a novel, first-of-its kind ...
(Date:5/20/2013)... Recognizing exciting and innovative scientific research, ... 2013 Class of Young Professors. Over the ... outstanding international group with more than $824,000 to ... meet global challenges.     , The DuPont Young Professor ... untenured research faculty working in areas of interest ...
(Date:5/20/2013)... Kitware, a leader in data visualization, today ... exploration of hospital costs across the United States ... recent release of “Medicare Provider Charge Data,” a dataset ... from the Centers for Medicare & Medicaid Services. , ... hospitals across the country has sparked considerable controversy; however, ...
Breaking Biology Technology:Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4DuPont Celebrates Scientific Innovation by Recognizing Young Professors 2DuPont Celebrates Scientific Innovation by Recognizing Young Professors 3Kitware Enables Interactive Exploration of CMS Medicare Data 2
... UltraTape Industries, a division,of Delphon Industries and ... today the availability of sample kits for ... are currently 5,sample kits available including those ... Tapes, ESD Tapes, Medical and,Pharmaceutical Tapes, and ...
... CLARA, Calif., April 22 /PRNewswire/,-- Agendia BV, a ... molecular,diagnostics, and Agilent Technologies, Inc. (NYSE: A ... collaborate to develop new in-vitro,diagnostic tests. In addition, ... products will continue to be supplied on Agilent ...
... $250,000 under March ... ... BMRX), a leading developer and supplier of consumer-based,finger-activated products, today announced ... personnel of Sequiam,Corporation (OTC Bulletin Board: SQUME) through a previously announced,agreement ...
Cached Biology Technology:UltraTape Announces Sample Kits Available for Purchase Through Website 2Agendia and Agilent Announce Plans to Jointly Develop New Diagnostic Tests, Extend Supply Agreement 2Agendia and Agilent Announce Plans to Jointly Develop New Diagnostic Tests, Extend Supply Agreement 3bioMETRX, Inc. Initiates Integration of Personnel and Assets of Sequiam Corp. 2
(Date:5/16/2013)... Illustrating a commitment to the support of ... (AGA) Research Foundation has announced the inaugural AGA ... recipients. Supported by the National Institute of Diabetes ... award helps underrepresented minority students to further their ... , "By establishing this new award, AGA demonstrates ...
(Date:5/16/2013)... ancient shorelines to predict the stability of today,s largest ice ... from three million years ago, for example when Earth ... be evidence of a high sea level due to ice ... scientists to think that if the world,s largest ice sheets ... same in our modern, progressively warming world. , However, ...
(Date:5/16/2013)... 2013 The relationship between the heritable risk ... been clear. Schizophrenia is commonly associated with cognitive ... clues that reduced IQ may be linked to ... cognitive ability may precede the onset of schizophrenia ... healthy relatives of people diagnosed with schizophrenia. , ...
Breaking Biology News(10 mins):Underrepresented minority students receive fellowships in digestive disease and nutrition research 2World's biggest ice sheets likely more stable than previously believed 2Genetic risk for schizophrenia is connected to reduced IQ 2
... Innes Centre in Norwich have discovered how roots find their ... in the forthcoming edition of Science, also explains how germinating ... burrow. The key is in the fuzzy coat of ... We have identified a growth control mechanism that enables these ...
... important discovery has been made with respect to the mystery ... research professor at Arizona State University, found that some of ... Earth have been shown to carry handedness in a larger ... in this weeks Early Edition of the Proceedings of the ...
... technique that combines low temperature measurements and theoretical calculations, ... for the first time the electronic structure of single ... properties of DNA is an important issue in many ... in the study of DNA damage by ultraviolet radiation ...
Cached Biology News:ASU researcher may have discovered key to life before its origin on Earth 2Electronic structure of DNA revealed for 1st time by Hebrew University and collaborating researchers 2
... is an affordable, compact benchtop imager ... providing a broad array of automated ... high-resolution images with high-performance laser autofocus, ... and emission filter changers, and a ...
... include: Microarray hybridization chamber assembly (1 ... clamp, thumbscrew) Microarray chamber user guide ... intended to be cleaned and reused. The ... Catalog Oligo Microarray kits and all custom ...
... Blood Vessel Staining Kit is a very ... vascular endothelial cells, containing both anti-von Willebrand ... applicable to a variety of species. This ... for the staining of frozen and paraffin-embedded ...
... Ham's F-12 was developed for culturing hybrid ... The modification consists of doubling the amino ... The salt concentrations have been altered as ... sulfate per liter, which may render it ...
Biology Products: